Rapilin (Gan & Lee Insulin Aspart biosimilar) / Sandoz, Novartis, Gan & Lee Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rapilin (Gan & Lee Insulin Aspart biosimilar) / Gan & Lee Pharma, Sandoz
NCT04237129: PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males

Completed
1
36
Europe
Gan & Lee Insulin Aspart, NovoRapid® EU, NovoLog® US
Gan and Lee Pharmaceuticals, USA
Diabetes Mellitus, Type 1
12/19
12/19

Download Options